Annual CFO:
-$225.97M-$59.66M(-35.88%)Summary
- As of today, CRNX annual cash from operations is -$225.97 million, with the most recent change of -$59.66 million (-35.88%) on December 31, 2024.
- During the last 3 years, CRNX annual cash from operations has fallen by -$137.38 million (-155.08%).
- CRNX annual cash from operations is now -4032.59% below its all-time high of -$5.47 million, reached on December 31, 2016.
Performance
CRNX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$85.85M+$2.60M(+2.94%)Summary
- As of today, CRNX quarterly cash from operations is -$85.85 million, with the most recent change of +$2.60 million (+2.94%) on June 30, 2025.
- Over the past year, CRNX quarterly cash from operations has dropped by -$38.21 million (-80.19%).
- CRNX quarterly cash from operations is now -3590.93% below its all-time high of -$2.33 million, reached on March 31, 2017.
Performance
CRNX Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$299.77M-$38.21M(-14.61%)Summary
- As of today, CRNX TTM cash from operations is -$299.77 million, with the most recent change of -$38.21 million (-14.61%) on June 30, 2025.
- Over the past year, CRNX TTM cash from operations has dropped by -$119.42 million (-66.21%).
- CRNX TTM cash from operations is now -12787.92% below its all-time high of -$2.33 million, reached on March 31, 2017.
Performance
CRNX TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CRNX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -35.9% | -80.2% | -66.2% |
| 3Y3 Years | -155.1% | -206.9% | -232.7% |
| 5Y5 Years | -387.2% | -441.5% | -403.5% |
CRNX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -155.1% | at low | -143.8% | +2.9% | -191.3% | at low |
| 5Y | 5-Year | -387.2% | at low | -533.9% | +2.9% | -403.5% | at low |
| All-Time | All-Time | -4032.6% | at low | -3590.9% | +2.9% | >-9999.0% | at low |
CRNX Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$85.85M(+2.9%) | -$299.77M(-14.6%) |
| Mar 2025 | - | -$88.45M(-36.8%) | -$261.57M(-15.8%) |
| Dec 2024 | -$225.97M(-35.9%) | -$64.67M(-6.4%) | -$225.97M(-13.1%) |
| Sep 2024 | - | -$60.80M(-27.6%) | -$199.81M(-10.8%) |
| Jun 2024 | - | -$47.64M(+9.9%) | -$180.35M(-1.1%) |
| Mar 2024 | - | -$52.86M(-37.2%) | -$178.44M(-7.3%) |
| Dec 2023 | -$166.31M(-44.4%) | -$38.52M(+6.8%) | -$166.31M(-2.0%) |
| Sep 2023 | - | -$41.34M(+9.6%) | -$163.00M(-1.8%) |
| Jun 2023 | - | -$45.73M(-12.3%) | -$160.14M(-12.5%) |
| Mar 2023 | - | -$40.72M(-15.7%) | -$142.38M(-23.6%) |
| Dec 2022 | -$115.20M(-30.0%) | -$35.21M(+8.5%) | -$115.20M(-12.0%) |
| Sep 2022 | - | -$38.48M(-37.5%) | -$102.90M(-14.2%) |
| Jun 2022 | - | -$27.98M(-106.6%) | -$90.09M(-9.8%) |
| Mar 2022 | - | -$13.54M(+40.9%) | -$82.06M(+7.4%) |
| Dec 2021 | -$88.59M | -$22.90M(+10.8%) | -$88.59M(-8.5%) |
| Sep 2021 | - | -$25.67M(-28.7%) | -$81.63M(-10.4%) |
| Jun 2021 | - | -$19.95M(+0.6%) | -$73.96M(-5.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$20.07M(-25.9%) | -$69.86M(-12.6%) |
| Dec 2020 | -$62.03M(-33.7%) | -$15.94M(+11.5%) | -$62.03M(-4.2%) |
| Sep 2020 | - | -$18.00M(-13.6%) | -$59.54M(-8.0%) |
| Jun 2020 | - | -$15.86M(-29.6%) | -$55.14M(-6.3%) |
| Mar 2020 | - | -$12.23M(+9.1%) | -$51.85M(-11.8%) |
| Dec 2019 | -$46.38M(-138.4%) | -$13.45M(+1.2%) | -$46.38M(-19.1%) |
| Sep 2019 | - | -$13.61M(-8.3%) | -$38.94M(-25.5%) |
| Jun 2019 | - | -$12.57M(-85.9%) | -$31.03M(-36.0%) |
| Mar 2019 | - | -$6.76M(-12.5%) | -$22.81M(-17.2%) |
| Dec 2018 | -$19.46M(-105.3%) | -$6.01M(-5.6%) | -$19.46M(-21.9%) |
| Sep 2018 | - | -$5.69M(-30.9%) | -$15.96M(-25.6%) |
| Jun 2018 | - | -$4.35M(-27.7%) | -$12.71M(-52.0%) |
| Mar 2018 | - | -$3.41M(-35.7%) | -$8.36M(-14.8%) |
| Dec 2017 | -$9.48M(-73.4%) | -$2.51M(-2.8%) | -$7.28M(-52.7%) |
| Sep 2017 | - | -$2.44M(-5.0%) | -$4.77M(-105.0%) |
| Mar 2017 | - | -$2.33M | -$2.33M |
| Dec 2016 | -$5.47M | - | - |
FAQ
- What is Crinetics Pharmaceuticals, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. annual cash from operations year-on-year change?
- What is Crinetics Pharmaceuticals, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
- What is Crinetics Pharmaceuticals, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. TTM cash from operations year-on-year change?
What is Crinetics Pharmaceuticals, Inc. annual cash from operations?
The current annual cash from operations of CRNX is -$225.97M
What is the all-time high annual cash from operations for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high annual cash from operations is -$5.47M
What is Crinetics Pharmaceuticals, Inc. annual cash from operations year-on-year change?
Over the past year, CRNX annual cash from operations has changed by -$59.66M (-35.88%)
What is Crinetics Pharmaceuticals, Inc. quarterly cash from operations?
The current quarterly cash from operations of CRNX is -$85.85M
What is the all-time high quarterly cash from operations for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high quarterly cash from operations is -$2.33M
What is Crinetics Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
Over the past year, CRNX quarterly cash from operations has changed by -$38.21M (-80.19%)
What is Crinetics Pharmaceuticals, Inc. TTM cash from operations?
The current TTM cash from operations of CRNX is -$299.77M
What is the all-time high TTM cash from operations for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high TTM cash from operations is -$2.33M
What is Crinetics Pharmaceuticals, Inc. TTM cash from operations year-on-year change?
Over the past year, CRNX TTM cash from operations has changed by -$119.42M (-66.21%)